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INTRODUCTION AND BACKGROUND
Significant risks for visual impairment associated with increased intracranial pressure
(VIIP) are incurred by microgravity spaceflight, especially by long-duration missions [1].
We hypothesize that microgravity-induced fluid shifts result in pathological changes
within the retinal blood vessels that precede development of visual and other ocular
impairments. Potential contributions of retinal vascular remodeling to VIIP etiology are
therefore being investigated by NASA’s innovative VESsel GENeration Analysis
(VESGEN) software [2,3] with two studies: (1) human subjects before and after 70 days
of bed rest (BR) with head-down tilt (HDT), and (2) U.S. crew members before and after
ISS missions. One goal of our VESGEN HDT study was to develop the analysis of 30°
Heidelberg Spectralis images in preparation for our astronaut study [IWS Abstract 7324].
VESGEN analysis previously identified surprising new opportunities for regenerating
retinal vessels during early-stage, potentially reversible progression of a visually
impairing and blinding disease supported by the US National Institutes of Health [2].
METHODS
For the NASA NRA award, we are analyzing with VESGEN the clinical ophthalmic
images of retinal blood vessels obtained by 30° infrared (IR) Heidelberg Spectralis®
(average image resolution, 11.4 μm/px). The 40 images were collected in the two
eyes of six healthy subjects before, during and after 70 days of bed rest at 6° HDT.
For this NASA IRB-approved retrospective study of NASA Bed Rest Campaign 11,
the VESGEN retinal analysis is being conducted in a randomized fashion without
knowledge of the subjects’ identity or temporal sequence of the images. VESGEN
(NASA patent pending) is a mature, automated software developed as a
translational and basic vascular research discovery tool [3,4], particularly for retinal
vascular disease [2,3]. Binary branching patterns of venous and arterial trees
extracted from the Spectralis® images with Adobe Photoshop® are automatically
mapped by VESGEN into vessel branching generations (Gx) and quantified by
parameters that include generation-dependent densities of vessel length (Lv), area
(Av), number (Nv) and fractal dimension (Df).
RESULTS AND DISCUSSION
VESGEN analysis of the venous branching in one image for each of the 12 eyes
of the six study subjects is complete. Two results for our preliminary study are
reported here: (1) Two populations were detected by VESGEN analysis that are
distinguished primarily by the presence or absence of small veins (Figure 1).
Results for the 12 arterial trees are in progress. (2) The smaller vessels are not
easily extracted from the grainy image background. However, small blood vessels
are of critical importance because generally they remodel more actively than large
vessels during progression of vascular-dependent diseases [2,3]. To estimate more
objectively any differences in small vessel patterning before, during and after HDT,
we therefore plan to complete the study by using the first 12 images as masking
templates. We will investigate whether our image masking approach offers higher
confidence in accurate vessel segmentation of the remaining HDT images prior to
performing the automated VESGEN analysis. We note that HDT subjects remained
asymptomatic throughout the duration of BR. Clinically relevant ocular structural or
functional changes were not observed.
CONCLUSIONS
By VESGEN analysis, two populations of the 12 subject retinas clearly differed in the
presence or absence of small veins. These differences may result from: (1) effects of
HDT, (2) pre-existing variation in the retinal vessels of the HDT subjects, or (3) limits in
the resolution capabilities of the IR Spectralis® imaging. Final results of our investigation
will be completed later this year that should help determine which explanation for the two
populations is correct.
Modified retinal vascular patterning may offer early-stage predictions of downstream
ocular changes that result in decreased visual acuity. Novel insights provided by
VESGEN may help to guide new etiological insights into the progression of VIIP and
consequently, future development of successful countermeasures.
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Figure 1 Two Populations of HDT Study Subjects Differ in Small Veins
The presence or absence of small veins (G≥7) distinguish two populations identified by VESGEN analysis from 12
retinas of six subjects that participated in a 70-day HDT campaign. Representative Spectralis® images of the two
populations identified by VESGEN (A,C) are displayed together with the VESGEN generational mappings of venous
(B,D) trees extracted from the images. For example, Lv≥7 and Av≥7 are 2.7 ± 1.3 E-4 μm/μm2 and 7.2 ± 3.6 E-4
μm2/μm2 for venous density in six retinas displaying smaller vessels, but zero in the other six retinas (mean ± SD).
Nonetheless, the space-filling properties of the entire venous trees are quite uniform in both populations by all
parameters, such as Df = 1.56 ± 0.02 for 6 retinas with G≥7 and 1.55 ± 0.02 for retinas without G≥7.
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